ArticleVaccine2025

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.

C N Mburu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.